Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C42H62N2O4S |
| Molecular Weight | 691.018 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(C6=CC=C(C=C6)C(O)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)NCCN7CCS(=O)(=O)CC7
InChI
InChIKey=XDMUFNNPLXHNKA-ZTESCHFWSA-N
InChI=1S/C42H62N2O4S/c1-28(2)31-14-19-42(43-22-23-44-24-26-49(47,48)27-25-44)21-20-40(6)33(36(31)42)12-13-35-39(5)17-15-32(29-8-10-30(11-9-29)37(45)46)38(3,4)34(39)16-18-41(35,40)7/h8-11,15,31,33-36,43H,1,12-14,16-27H2,2-7H3,(H,45,46)/t31-,33+,34-,35+,36+,39-,40+,41+,42-/m0/s1
| Molecular Formula | C42H62N2O4S |
| Molecular Weight | 691.018 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:11:06 GMT 2025
by
admin
on
Mon Mar 31 23:11:06 GMT 2025
|
| Record UNII |
4CA9IAU7RJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4CA9IAU7RJ
Created by
admin on Mon Mar 31 23:11:06 GMT 2025 , Edited by admin on Mon Mar 31 23:11:06 GMT 2025
|
PRIMARY | |||
|
SUB197797
Created by
admin on Mon Mar 31 23:11:06 GMT 2025 , Edited by admin on Mon Mar 31 23:11:06 GMT 2025
|
PRIMARY | |||
|
BMS-955176
Created by
admin on Mon Mar 31 23:11:06 GMT 2025 , Edited by admin on Mon Mar 31 23:11:06 GMT 2025
|
PRIMARY | |||
|
DB15193
Created by
admin on Mon Mar 31 23:11:06 GMT 2025 , Edited by admin on Mon Mar 31 23:11:06 GMT 2025
|
PRIMARY | |||
|
DTXSID401336145
Created by
admin on Mon Mar 31 23:11:06 GMT 2025 , Edited by admin on Mon Mar 31 23:11:06 GMT 2025
|
PRIMARY | |||
|
1392312-45-6
Created by
admin on Mon Mar 31 23:11:06 GMT 2025 , Edited by admin on Mon Mar 31 23:11:06 GMT 2025
|
PRIMARY | |||
|
60152109
Created by
admin on Mon Mar 31 23:11:06 GMT 2025 , Edited by admin on Mon Mar 31 23:11:06 GMT 2025
|
PRIMARY | |||
|
100000183335
Created by
admin on Mon Mar 31 23:11:06 GMT 2025 , Edited by admin on Mon Mar 31 23:11:06 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
TARGET ORGANISM->INHIBITOR |
The observation of gastrointestinal intolerability and the emergence of resistant virus led to the cessation of development activities in favor of compounds with improved antiviral profiles.
EC50
|
||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |